Skip to main content
Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 29, 2026

Aridis Pharmaceuticals Revenue

Aridis Pharmaceuticals had revenue of $417.00K in the quarter ending September 30, 2023, with 4.51% growth. This brings the company's revenue in the last twelve months to $22.36M, up 680.42% year-over-year. In the year 2022, Aridis Pharmaceuticals had annual revenue of $3.09M with 101.37% growth.

Revenue (ttm)
22.36M
Revenue Growth
+680.42%
P/S Ratio
0.00
Revenue / Employee
604.30K
Employees
37
Market Cap
10.66K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20223.09M1.56M101.37%
Dec 31, 20211.54M535.00K53.50%
Dec 31, 20201.00M-22.00K-2.15%
Dec 31, 20191.02M-1.74M-62.93%
Dec 31, 20182.76M1.90M220.58%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Trevena 546.00K
GeneLink 1.58M
Syros Pharmaceuticals 386.00K
Navidea Biopharmaceuticals 610.00
ObsEva 19.64M
Bioasis Technologies 199.01K
Therapeutic Solutions International 85.32K
Revenue Rankings

Aridis Pharmaceuticals News

More News